These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 17880921)
1. Chemically modified siRNA prolonged RNA interference in renal disease. Takabatake Y; Isaka Y; Mizui M; Kawachi H; Takahara S; Imai E Biochem Biophys Res Commun; 2007 Nov; 363(2):432-7. PubMed ID: 17880921 [TBL] [Abstract][Full Text] [Related]
2. Exploring RNA interference as a therapeutic strategy for renal disease. Takabatake Y; Isaka Y; Mizui M; Kawachi H; Shimizu F; Ito T; Hori M; Imai E Gene Ther; 2005 Jun; 12(12):965-73. PubMed ID: 15729369 [TBL] [Abstract][Full Text] [Related]
3. In vivo transfer of small interfering RNA or small hairpin RNA targeting glomeruli. Takabatake Y; Isaka Y; Imai E Methods Mol Biol; 2009; 466():251-63. PubMed ID: 19148605 [TBL] [Abstract][Full Text] [Related]
4. siRNA-based therapy ameliorates glomerulonephritis. Shimizu H; Hori Y; Kaname S; Yamada K; Nishiyama N; Matsumoto S; Miyata K; Oba M; Yamada A; Kataoka K; Fujita T J Am Soc Nephrol; 2010 Apr; 21(4):622-33. PubMed ID: 20203158 [TBL] [Abstract][Full Text] [Related]
5. [Effects of siRNAs silencing transforming growth factor-beta1 on fibronectin in SD rat masangial cells]. Mao HX; Yi ZW; Wu XC; Dang XQ; He XJ; Cao Y; Mo SH Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):494-7. PubMed ID: 17953803 [TBL] [Abstract][Full Text] [Related]
6. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis. D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267 [TBL] [Abstract][Full Text] [Related]
7. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
10. The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats. Lang Q; Liu Q; Xu N; Qian KL; Qi JH; Sun YC; Xiao L; Shi XF Biochem Biophys Res Commun; 2011 Jun; 409(3):448-53. PubMed ID: 21600192 [TBL] [Abstract][Full Text] [Related]
11. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
12. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. Aigner A J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Hwang M; Kim HJ; Noh HJ; Chang YC; Chae YM; Kim KH; Jeon JP; Lee TS; Oh HK; Lee YS; Park KK Exp Mol Pathol; 2006 Aug; 81(1):48-54. PubMed ID: 16443218 [TBL] [Abstract][Full Text] [Related]
15. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production. Li G; Li D; Xie Q; Shi Y; Jiang S; Jin Y J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219 [TBL] [Abstract][Full Text] [Related]
16. Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia. Arnold AS; Tang YL; Qian K; Shen L; Valencia V; Phillips MI; Zhang YC J Hypertens; 2007 Jan; 25(1):197-205. PubMed ID: 17143192 [TBL] [Abstract][Full Text] [Related]
17. Profiling RNA interference (RNAi)-mediated toxicity in neural cultures for effective short interfering RNA design. Read ML; Mir S; Spice R; Seabright RJ; Suggate EL; Ahmed Z; Berry M; Logan A J Gene Med; 2009 Jun; 11(6):523-34. PubMed ID: 19322910 [TBL] [Abstract][Full Text] [Related]
18. Local action of endogenous renal tubular atrial natriuretic peptide. Lo CS; Chen CH; Hsieh TJ; Lin KD; Hsiao PJ; Shin SJ J Cell Physiol; 2009 Jun; 219(3):776-86. PubMed ID: 19229880 [TBL] [Abstract][Full Text] [Related]
19. [Construction and assessment of short-hairpin RNA eukaryotic expression vector targeting TGF-beta1 labeled by GFP]. Han YL; Li N; Kang J; Qi YM; Guo L; Yan CH Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):244-9. PubMed ID: 21189563 [TBL] [Abstract][Full Text] [Related]
20. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]